[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Market Updates by ScanX [@mupdatesbyscanx](/creator/twitter/mupdatesbyscanx) on x XXX followers Created: 2025-07-21 15:08:26 UTC Dr Reddys Laboratories (DRREDDY) on NSE: 1259.30 (+0.14%) Dr. Reddy's New York API Facility Receives USFDA Approval with VAI Status View: Positive Dr Reddy's Laboratories' Active Pharmaceutical Ingredient (API) facility in Middleburgh, New York, has received an Establishment Inspection Report (EIR) from the USFDA with a 'Voluntary Action Indicated' (VAI) status. The inspection is officially closed under XX CFR 20.64(d)(3). This outcome allows the facility to continue operations without significant regulatory hurdles, indicating ongoing compliance with FDA standards. The company views this as a positive development, reinforcing its position in the global pharmaceutical market. Read more: #Stocks #Market #DRREDDY  XXX engagements  **Related Topics** [vai](/topic/vai) [$drreddyns](/topic/$drreddyns) [dr reddys](/topic/dr-reddys) [Post Link](https://x.com/mupdatesbyscanx/status/1947312721097290122)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Market Updates by ScanX @mupdatesbyscanx on x XXX followers
Created: 2025-07-21 15:08:26 UTC
Dr Reddys Laboratories (DRREDDY) on NSE: 1259.30 (+0.14%)
Dr. Reddy's New York API Facility Receives USFDA Approval with VAI Status
View: Positive
Dr Reddy's Laboratories' Active Pharmaceutical Ingredient (API) facility in Middleburgh, New York, has received an Establishment Inspection Report (EIR) from the USFDA with a 'Voluntary Action Indicated' (VAI) status. The inspection is officially closed under XX CFR 20.64(d)(3). This outcome allows the facility to continue operations without significant regulatory hurdles, indicating ongoing compliance with FDA standards. The company views this as a positive development, reinforcing its position in the global pharmaceutical market.
Read more:
#Stocks #Market #DRREDDY
XXX engagements
Related Topics vai $drreddyns dr reddys
/post/tweet::1947312721097290122